Unnamed: 0,text,n,cmem_n_89reports_ans_str,cmem_n_89reasoning,cmem_n_96reports_ans_str,cmem_n_96reasoning,Has_Valid_Prediction,coded_pred
957,"AP Surgical Pathology: Additional Info. I. CLINICAL HISTORY: of known carcinoma right 10:00 breast. If invasive carcinoma, please results. Biopsy obtain ER, PR, EGFR, HER2/Neu by immunohistochemistry; for all 2+ IHC. please do FISH analysis. A. GROSS ""USNCB right breast, five cores 10:00 area"". Received in formalin is a 1.7 in. EXAMINATION: x. 1 x 0.2 cm aggregate of fibrofatty needle core tissue submitted entirely. a mesh bag in block A1. MICROSCOPIC EXAMINATION: Microscopic examination is performed. DIAGNOSIS: A. ""USNCB RIGHT BREAST, FIVE CORES 10:00 AREA"": INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 3. LYMPHATIC/VASCULAR INVASION: NOT IDENTIFIED. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: COMEDO. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. MICROCALCIFICATIONS ABSENT. ESTROGEN/PROGESTERONE RECEPTOR, HER2/NEU, AND EGFR ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: A1. RESULTS WILL BE ISSUED IN AN ADDENDUM. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . AT ADDENDUM 1: for results of supplementary. Please see. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). Attending MD: T.",2,N0,"The pathology report does not provide information about the presence or extent of cancer in nearby lymph nodes. According to Rule 12, the N stage is determined by the number of positive lymph nodes, and in this case, there is no mention of positive lymph nodes. Therefore, the N stage is N0 (no cancer in nearby lymph nodes).",N0,"The report does not mention the presence or extent of cancer in nearby lymph nodes. According to Rule 12, the N stage is determined by the number of positive lymph nodes, and in this case, there is no mention of any positive lymph nodes. Therefore, the N stage is N0.",True,0
938,"Gurgical. Patho. CLINICAL HISTORY: S/P tru cut biopsy of 3.5 cm breast self detected lesion. Moderately. differentiated NSABP II, grade adenocarcinoma. Breast carcinoma. GROSS EXAMINATION: A. ""Right breast mass"", in formalin. A 4 x 3 x 1.5 cm piece of yellow-white. fibrofatty breast tissue containing a 3.5 x 3 x 2 cm firm, gritty, white-pink,. infiltrating tumor. Margins are not an issue for this specimen per Dr. therefore, the specimen is not inked. Representative sections of. the tumor are submitted in Blocks A1-A3. B. ""Right breast"", unfixed. A 22 x 15 x 5 cm mastectomy specimen with. axillary tail. The breast has a 19 x 13 cm skin ellipse containing nipple and. areola with a 6 cm long horizontal sutured biopsy site located directly above. the nipple. The external surface of the breast is inked in black. The skin surface, nipple and areola are grossly unremarkable. Cross sectioning through the breast specimen reveals a soft yellow-white. fibrofatty breast parenchyma along with an 8 x 6 x 5 cm hollow biopsy cavity. running in a horizontal direction beneath the nipple which is lined by pink,. thin, smooth, membranous tissue. No residual tumor is identified. The edges. of the biopsy cavity lie 3 cm, 1 cm, 7 cm and 7 cm from the superior,. deep/posterior and inferior inked tissue margins. No other lesions are noted. BLOCK SUMMARY: B1 representative section of nipple. B2 biopsy cavity and corresponding inked deep/posterior surface. B3-B4 additional sections of biopsy cavity. B5-B6 representative sections of upper lateral portion of breast. B7-B8 representative sections of lower lateral portion of breast. B9-B10 representative sections of upper medial portion of breast. B11-B12 representative sections of lower medial portion of breast. B13 1 bisected lymph node candidate from most medial portion of axillary. tail. B14. 2 lymph node candidates from most medial portion of axillary tail. B15. 3 lymph node candidates from the middle portion of the axillary tail. B16. 2 lymph node candidates from the middle portion of the axillary tail. B17. 1 bisected lymph node candidate from the middle portion of the axillary. tail. B18 2 lymph node candidates from the middle portion of the axillary tail. B19 2 lymph node candidates from the most lateral portion of. tail. Dr. DIAGNOSIS: A. ""RIGHT BREAST"", (BIOPSY) : INFILTRATING DUCTAL CARCINOMA. 3.5 x 3 x 2. NSABP HISTOLOGIC GRADE 2 OF 3, NUCLEAR GRADE MODERATELY DIFFERENTIATED. VASCULAR INVASION IDENTIFIED. B. ""RIGHT BREAST"", (MASTECTOMY WITH AXILLARY TAIL) : BREAST: NO RESIDUAL CARCINOMA. BENIGN PROLIFERATIVE CHANGES, INCLUDING EPITHELIAL HYPERPLASIA OF USUAL. TYPE AND BLUNT DUCT ADENOSIS. RECENT BIOPSY CAVITY WITH NO EVIDENCE OF MALIGNANCY. SKIN AND NIPPLE WITH NO HISTOLOGIC ABNORMALITY. AXILLARY LYMPH NODES. METASTATIC CARCINOMA IN 4 OF 7 LYMPH NODES. EXTRACAPSULAR SPREAD PRESENT. LARGEST LYMPH NODE 2.1 CM. M.D. Pager ID#. COMMENT:",1,N2,"The N stage is determined by the presence and extent of cancer in nearby lymph nodes. From the report, we can see that metastatic carcinoma was found in 4 out of 7 lymph nodes, with extracapsular spread present. The size of the lymph nodes or the presence of cancer in other lymph nodes or organs does not affect the N stage. Therefore, based on Rule 12, the N stage is N2.",N2,"According to the report, there are 4 positive lymph nodes out of 7 examined (B13-B18) in the right axillary tail. This corresponds to N2 (metastasis in 1-3 axillary lymph nodes or in clinically apparent ipsilateral internal mammary nodes) based on Rule 12, which states that the N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases. The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs (Rule 13), or by the size of the metastases in the positive lymph nodes (Rule 14). The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel) (Rule 15).",True,2
1174,"page 1 / 2. copy No. 3. Examination: Histopathological examination. Gender: F. Material: Multiple organ resection - right breast. Material collected on: : Expected time of examination: up to 8 working days. Clinical diagnosis: Examination performed or. Macroscopic description: Right breast sized 21.5 x 14 x 4 cm removed without axillary tissues and with a skin flap of 15 x7 cm. Tumour sized. 3.0 x 1.4 x 1.8 cm on the boundary of outer quadrants, located 3 cm from the lower boundary, 3 cm from the base. and 1 cm from the skin. Microscopic description: Carcinoma mammae invasivum- NHG2 (3+2+1:5 mitoses/10 HPF - visual area: 0.55mm). Lesions of the type mastopathia fibrosa et cystica. Metastases carcinomatosae in lymphonodis. Infiltratio capsulae lymphonodi et telae perinodalis. Histopathological diagnosis: Invasive lobular carcinoma of the right breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) Rabbit Monoclonal Antibody. Negative reaction in invasive cancerous cells (Score=1+). Examination: Histopathological examination. page 2 / 2. Gender: F. Examination result: Carcinoma lobulare invasivum mammae dextrae. Metastases carcinomatosae in lymphonodis axillae (No II/II) (NHG2, pT2, pNla). Following immunohistopathological tests were made:: E - cadheryna. Compliance validated hu.",3,N1,"The report mentions 'Metastases carcinomatosae in lymphonodis. Infiltratio capsulae lymphonodi et telae perinodalis.' This indicates that cancer has been found in nearby lymph nodes. However, the report does not provide the exact number of positive lymph nodes. As a result, we cannot use the specific N stage rules (N0, N1, N2, N3) that require a specific number of positive lymph nodes. Instead, we can only determine that the N stage is not N0 (since cancer has been found in nearby lymph nodes). Therefore, the N stage is either N1, N2, or N3. However, without the exact number of positive lymph nodes, we cannot determine the exact N stage. Based on the information provided, the N stage is most likely N1, since the report mentions only one site of metastasis (axillary lymph nodes) and does not mention any distant metastasis. But, again, without the exact number of positive lymph nodes, we cannot determine the exact N stage.",N1,"The report mentions 'Metastases carcinomatosae in lymphonodis. Infiltratio capsulae lymphonodi et telae perinodalis.' This indicates that cancer has been found in nearby lymph nodes. However, the report does not provide the exact number of positive lymph nodes. As a result, we cannot use the specific N stage rules (N0, N1, N2, N3) that require a specific number of positive lymph nodes. Instead, we can only determine that the N stage is not N0 (since there are positive lymph nodes). Therefore, the N stage is either N1, N2, or N3. Based on the information provided, we cannot distinguish between these three options. However, since N1 is the lowest possible stage that fits the information in the report, we can predict that the N stage is N1.",True,1
814,"Cinical Diagnosis & History: y/o female with left breast IDC and DCIS, now for segmental resection and. SLNB. Specimens Submitted: 1: SP: Sentincl node #1, level 1, left axilla (fs). 2: SP: Sentinel node #2, level 1, left axilla I. 3: SP: Sentinel node #3, level 1, left axilla. 4: SP: Sentinel node #4, level 1, left axilla. 5: SP: Left axillary contents levels 1, 2 and 3. 6 : SP: Additional level 3 nodes, left axilla. 7: SP: Left breast mannographic mass. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I LEFT AXILLA BIOPSY: - METASTATIC MAMMARY CARCINOMA IN ONE OF ONE LYMPH NODE (1/1) -. to EXTRANODAL EXTENSION IS PRESENT (>2 MM). LYMPH NODE, SENTINEL #2 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1) WITH A TUMOR EMBOLUS IN PERINODAL. LYMPHATIC VESSEL. 3). LYMPH NODE, SENTINEL #3 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 4). LYMPH NODE, SENTINEL #4 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 5). AXILLARY CONTENTS, LEFT LEVELS I, II AND III; DISSECTION: LEVEL I: A MICROSCOPIC FOCUS OF METASTATIC MAMMARY CARCINOMA IN ONE. OF THREE LYMPH NODES (1/3). - LEVEL II: EIGHTEEN BENIGN LYMPH NODES (0/18) . - LEVEL III: SIX BENIGN LYMPH NODES (0/6). LYMPH NODE, ADDITIONAL LEVEL III LEFT AXILLA; EXCISION: - BENIGN ADIPOSE TISSUE WITH MICROSCOPIC LYMPHOID AGGREGATES. 7). BREAST, LEFT; EXCISION: - MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC. Page 2 or 6. GRADE II-III/III, NUCLEAR GRADE II/III, RANGING IN SIZE FROM 0.1 0x UP TO. 2.5 CM (THE TWO LARGEST FOCI OF TUMOR MEASURE 1.4 CM AND 2.5 CM GROSSLY). A FEW FOCI OF DUCTAL CARCINOMA IN SITU (DCIS), SOLID AND CRIBRIFORM TYPES. WITH INTERMEDIATE NUCLEAR GRADE. NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. - PROMINENT VASCULAR INVASION IS PRESENT. INVASIVE CARCINOMA EXTENDS TO THE FOLLOWING SHAVED MARGINS: LATERAL (IN. 1/8 SLIDES, 0.6 CM) ; INFERIOR (IN 3/8 SLIDES, THE LARGEST FOCUS MEASURING. 0.8 CM). ANTERIOR (IN 4/19 SLIDES, THE LARGEST FOCUS MEASURING 0.5 CM): AND. POSTERIOR (IN 1/15 SLIDES, THE LARGEST FOCUS MEASURING 0.2 CM) IN. ADDITION, LYMPHATIC TUMOR EMBOLI ARE ALSO SEEN AT THE MARGINS. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY DCIS IS IDENTIFIED. - BIOPSY SITE CHANGES. - RESULTS OF SPECIAL STAINS (ER, PR, HER-2/NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. RECUT. RECUT. RECUT. RECUT. NEG CONT. IMM RECUT. ER-C. PR-c. HER2 C. NEG -HER2. Gross Description: 1). The specimen is received fresh for frozen section consultation. labcled, Sentinel node #1, level 1, left axilla"", and consists of a piece. of yellow-tan fatty tissue Deasuring 3.5 x 2 x 1 cm, containing firm gray. lymph node measuring 1.4 x 1 x 0.7 cm. Representative section is frozen. The remainder of the specimen is entirely submitted. Summary of Sections: FSC frozen section control. U - undesignated. vage 3 or b. 2). The specimen is received in formalin, labeled, ""Sentinel node #2,. level 1, left axilla"". It consists of a 0.9 x 0.5 x 0.4 cm tan lymph node. with attached adipose tissue. The entire lymph node is submitted. Summary of Sections: LN - lymph node. 3). The specimen is received in formalin, labeled, ""Sentinel node #3,. level 1, left axilla"". It consists of a 1.3 x 0.4 x 0.3 cm tan lymph node. The lymph node is entirely submitted. Summary of Sections: LN - lymph node. 4). The specimen is received in formalin, labeled, ""Sentinel node #4,. level 1, left axilla"". It consists of a 0.3 x 0.3 x 0.2 Cm tan lymph node. with attached adipose tissue. The lymph node is entirely submitted. Summary of Sections: LN - lymph node. 5). The specimen is received in formalin, labeled, ""Left axillary. contents levels 1, 2 and 3 (with tags attached) It consists of a. 17.0. x. 15.0 x 4.0 cm fragment of adipose tissue with metallic tags labeling levcls. 1 through 3. Multiple lymph nodes are identified within each level,. measuring from 0.2 to 2.8 ca in greatest dimension. All identified lymph. nodes are submitted. Summary of Sections: LIBLN level one bisected lymph node. LILNSS level one, one lymph node serially sectioned. LII level two lymph nodes. LIII level three lymph nodes. 6). The specimen is received in formalin, labeled, ""Additional level. 3. nodes , left axilla"". It consists of a 2.0 x 1.8 x 1.0 cm aggregate of. adipose tissue. No definite lymph nodes are identified. Entirely. submitted. Summary of Sections: U - undesignated. 7). The specimen is received fresh, labeled, ""Left breast nammographic. mass (short stitch superior, long stitch lateral)"". It consists of a 9.5 x. 8.0 x 5.3 cm fragment of fibroadipose tissue with a needle localizing wire. and sutures marking the superior and lateral margins. The specimen is inked. as follows: black-anterior and posterior, yellow-superior, green-inferior,. blue-lateral, red-medial. The margins are entirely shaved and submitted. There is a palpable mass at the lateral/inferior portion of the specimen. Serial sectioning reveals a 2.5 x 2.0 x 1.8 em firm white stellate mass,. located in the center of the specimen. closely approaching the anterior. margin. Noted adjacent to this mass, near or close to the medial margin is. a. second tan firm nodular mass, measuring 1.4 x 1.1 x 0.9 cm. The remaining. breast parenchyma is predominantly fatty with foci of fibrous tissue. NO. other lesions ure identified. Representative sections are submitted. Portions of both the larger and smaller tumors are submitted for TPS. Summary of Sections: M medial. L lateral. I inferior. A anterior. s superior. P posterior. LT larger tumor. ST smaller tumor. ADJ adjacent to tumor mass. RS representative sections. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, left axilla. Block. Sect. Site. PCs. 1. fsc. 1. 1. u. 1. Part 2: SP: Sentinel node #2, level 1, left axilla. Block. Sect. Site. PCs. 1. In. 1. Part 3: SP: Sentinel node #3, level 1, left axilla. Block. Sect. Site. PCs. 1. In. 1. Part 4: SP: Sentinel node #4, level 1, left axilla. Block. Sect. Site. PCs. 1. In. 1. Part 5: SP: Left axillary contents levels 1, 2 and 3 ,. Block. Sect. Site. PCs. yage 5 of 6. 2. LIBLN. 4. 5. LII. 10. 3. LIII. 6. 5. LILNSS. 5. Part 6: SP: Additional level 3 nodes, left axilla. Block. Sect. Site. PCs. 1. u. 1. Part 7: SP: Left breast marmographic mass. Block. Sect. Site. PCs. 19. a. 19. 2. adj. 2. 8. i. 13. 8. 1. 14. 4. 1t. 4. 4. m. 10. 15. p. 15. 5. rs. 5. 4. 10. 2. st. 2. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDENDUM REPORT. SITE: LEFT BREAST (PART #7). ER: 95% NUCLEAR STAINING WITH MODERATE INTENSITY. PR: 40% NUCLEAR STAINING WITH WEAK TO MODERATE INTENSITY. HER-2/NEU (HERCEPTEST) : POSITIVE (STAINING INTENSITY OF 3+). Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME.",1,N2,"The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases or the location (sentinel or non-sentinel). In this report, there is one positive sentinel lymph node (1/1) in level I with extranodal extension, and one positive non-sentinel lymph node (1/3) in level I. This results in a total of 2 positive lymph nodes. Therefore, the N stage is N2.",N2,"The N stage is determined by the presence and extent of cancer in nearby lymph nodes. According to the report, there is metastatic mammary carcinoma in one of one lymph node in sentinel node #1 level I left axilla, and a microscopic focus of metastatic mammary carcinoma in one of three lymph nodes in level I of the axillary contents. This means that there are positive lymph nodes in two separate anatomic locations, making the N stage N2. The number of positive lymph nodes and their anatomic location are the only factors that determine the N stage, so the presence or absence of cancer in other lymph nodes or organs, the size of the metastases in the positive lymph nodes, and the size of the primary tumor are not relevant. The substaging information can also be ignored.",True,2
